Excerpts

Only age in RCA territories approached significance ( P = 0.05), with viable territories showing slightly higher mean age (Table 3 ).

In the subtype analysis, gastric cancer showed a trend consistent with M1, but with higher overall values; AI assistance significantly improved both sensitivity (86.73%) and accuracy (89.85%) (both p< 0.05).

The association for obesity became borderline significant ( p = 0.05), with the adjusted odds ratio suggesting potentially lower odds of exercise (AOR = 0.81, 95% CI [0.66, 1.00]); the confidence interval just touching 1.00 indicates this finding is at the threshold of statistical significance.

Colocalisation We employed the Bayesian colocalisation method coloc 69 to assess whether the nominally significant (p-value < 0.05) MR effects observed for drug targets were indicative of causation or potentially confounded by linkage disequilibrium (LD) 70 .

In contrast to the OTR, the WVTR values exhibit a decreasing trend ( p < 0.05) as the concentration of ZnO-NPs increases.

Significant multivariate effects were observed for group (V = 0.0627, F (2,127) = 4.25, p =.016) and age (V = 0.155, F (2,127) = 11.64, p <.001), with motion approaching significance (V = 0.046, F (2,127) = 3.07, p =.05).

Between-protocol analyses for movement time changes approached but did not reach statistical significance (Friedman test: χ2(3) = 7.824, raw p = 0.050).

E = 0.448, p < 0.001), and DSP showed marginal significance ( p = 0.05).

However, NS 9 showed a slight significance (p < 0.05) increase in latency time at 3 h after which the latency began to decline.

After the rTMS treatment, the robotic rTMS group showed a trend-level decrease in the BDI scores (z = − 1.95, p = 0.05), whereas the manual rTMS group did not (z = − 1.48, p = 0.14).

Time had a highly significant ( P < 0.05) effect on all indices.

Additionally, certain indicators exhibited marginal significance differences (0.1 > p > 0.05), such as DriSucc% in the elite group and GCA, ShortCmp, Def 3rd, Mid 3rd and DriMis in the control group.

Compared with CK, SOC, POC and MAOC contents of B1 and B3 were significantly increased by 2.06 and 3.88 g kg −1 , 0.77 and 1.77 g kg −1 , 1.37 and 3.17 g kg −1 , respectively, showing an increasing trend with higher application rates ( P < 0.05 ).

In both the encoding and active storage phases, a marginally significant positive correlation was observed between ΔRT 3 − 2​ and ΔTheta 3 − 2​ ( r =.16, p =.05 for each phase).

The declining trend in RMS for the striking leg approached significance ( p < 0.05), whereas the supporting leg showed no significant changes.

Analysis of variance (ANOVA) indicated highly significant differences in OM and OC among treatments (p < 0.05).

Although limited by sample size, the P value for LMNA did not reach statistical significance ( P < 0.05), whereas CEBPB exhibited a significant response (Fig. 8 K, L).

For the interval between successive dual pulses (inter dual pulse time), differences among species were marginally significant (F3,46 = 2.79, p = 0.05).

The p value can be calculated to show the significant results statistically and depicts that results are highly significant ( P < 0.05).The relative gene expression of GCK and GLUT4 in T2DM patients without and with complication are shown in (Fig. 8 ).

Histomorphometric analysis: In general, the Os% in the g-C 3 N 4 and GO implanted defects displayed a highly significant difference ( P < 0.05) compared with the control defect throughout the experiment (Fig. 6 A).

Of these, 12 were nominally significant at P < 0.05 and none were nominally significant at P < 0.01 (Table 3 ).

Conversely, the indirect effect of PA on SW through PSS was significant ( β = 0.109; t = 6.599; p < 0.001), with a marginally significant direct effect ( β = 0.070; t = 1.960; p > 0.05), suggesting a complementary partial mediation.

For Experiments 2 (T24) and 3 (T23) the highly significant results gave evidence of a common phasing among animals (p < 0.002; Scheme 3, S3 ), while the Tidal T-cycle Experiments 5 (T t = 12.25) and 6 (T t = 12.65) each gave moderately significant evidence of common phasing (p = 0.05 and p = 0.01; Scheme 3, S3 ).

Similarly, AST levels were higher in the nanocurcumin group (38.44 ± 23.38 U/L) compared to the placebo group (27.21 ± 10.07 U/L), with a P -value approaching significance ( P = 0.05).

Table 3 shows highly significant differences between both groups of patients with age ≥ 8 years as regards UCVA and BCVA at visits 2, 3, and 4 ( p < 0.05).